BHF
Brighthouse Financial, Inc. Financials Life Insurance Russell 3000
$43.92Close
$2.5BMarket cap
$42.98 – $66.6152-week range
Nov 5, 2026Next report
Highlights
Strengths
- Earnings growing EPS +1052% year on year
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 11 · weaker than 89% of stocks over 12 months
- Far from its high 34% below its 52-week high
- Distribution down-day volume 2.2× up-day volume over 50 sessions
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
34%
1wk
down 3.3%
price change
1mo
down 12.0%
price change
12-month return
down 4%
market up 11% ·
its own down 16%
F-score
—
— Not assessed
Altman Z
—
Unknown
P/E
7.6×
price / earnings
PEG
0.33
P/E / EPS growth
P/B
0.4×
price / book
Earnings yield
—
EBIT / enterprise value
Cheaper than
—
of the market · not assessed
Revenue growth
up 43%
year on year
EPS growth
up 1052%
latest quarter
Sales growth
up 86%
latest quarter · +122 pts
ROE
up 6%
return on equity
Free cash margin
—
D/E
0.47
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
Repair signals
- FCF turned positive ($-290M → $259M)
Trade setup
ATR%
3.0%
$1.30 a day · 2×ATR $41.33
RS
11 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
0.8×
vs 50-day average
Up/down volume
0.46
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- No material dilution
- Margins and revenue not shrinking
Last reported
Aug 5, 2026
Results reaction
Aug 5, 20260% vs market2 sessions after results
Financials
- Net 5%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $8.5B | $5.0B | $6.9B | $4.1B | $4.7B | $6.8B |
| Net income | -$1.1B | $1.6B | $3.8B | -$1.2B | $286.0M | $331.0M |
| Net margin | -12% | 31% | 55% | -29% | 6% | 5% |
| Earnings per share | -$11.13 | $18.40 | $51.30 | -$18.39 | $4.64 | $5.71 |
| Cash | $4.1B | $4.5B | $4.1B | $3.9B | $5.0B | $5.4B |
| Long-term debt | $3.4B | $3.2B | $3.2B | $3.2B | $3.2B | $3.2B |
| Shareholders' equity | $18.0B | $16.1B | $5.5B | $4.9B | $5.0B | $6.8B |
| Shares outstanding | 88.21m | 77.87m | 68.28m | 63.50m | 58.63m | 57.17m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 7, 2026 | Quarterly ↗ | Mar 31, 2026 | 37d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Nov 7, 2025 | Quarterly ↗ | Sep 30, 2025 | 38d |
| Aug 8, 2025 | Quarterly ↗ | Jun 30, 2025 | 39d |
| May 9, 2025 | Quarterly ↗ | Mar 31, 2025 | 39d |
| Feb 28, 2025 | Annual ↗ | Dec 31, 2024 | 59d |
| Nov 8, 2024 | Quarterly ↗ | Sep 30, 2024 | 39d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Feb 22, 2024 | Annual ↗ | Dec 31, 2023 | 53d |
| Nov 8, 2023 | Quarterly ↗ | Sep 30, 2023 | 39d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 18, 2026 | Director or officer change ↗ |
| Aug 5, 2026 | Results ↗ |
| Jun 3, 2026 | Shareholder vote ↗ |
| May 6, 2026 | Results ↗ |
| Feb 23, 2026 | Results ↗ |
| Feb 12, 2026 | Shareholder vote · Regulation FD ↗ |
| Nov 7, 2025 | Results ↗ |
| Nov 6, 2025 | Other events ↗ |
| Nov 6, 2025 | Material agreement · Results · Regulation FD ↗ |
| Sep 2, 2025 | Director or officer change ↗ |
| Aug 7, 2025 | Results · Regulation FD ↗ |
| Jun 16, 2025 | Director or officer change · Shareholder vote ↗ |